To demonstrate a dosage regimen for intravenous itraconazole that produces a plasma concentration range comparable to that obtained after currently used oral dosages of itraconazole oral solution; and to obtain preliminary safety data in patients with advanced HIV disease.
Patients will receive intravenous itraconazole solution twice daily for 2 days and then once daily for five additional days. Patients then randomized to receive twice-daily or once-daily itraconazole oral solution for an additional 28 days.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Enrollment
36
Erie County Med Ctr / Pharmacy D
Buffalo, New York, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.